"L’Institut Curie, acteur de référence de la lutte contre le cancer, associe un Centre de Recherche de renommée internationale et un Ensemble Hospitalier de pointe qui prend en charge tous les cancers, y compris les plus rares. Fondé en 1909 par Marie Curie, l’Institut Curie rassemble sur trois sites (Paris, Saint-Cloud, Orsay) plus de 3 300 chercheurs, médecins et soignants autour de trois missions : la recherche, les soins et la conservation et la transmission des savoirs. Fondation privée reconnue d’utilité publique habilitée à recevoir des dons et des legs, l’Institut Curie peut, grâce au soutien de ses donateurs, favoriser les découvertes et ainsi améliorer les traitements et la qualité de vie des malades."

During the past decade, Institut Curie - Ulm - Paris conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institut Curie - Ulm - Paris" are "Advanced Non-small Cell Lung Cancer" (1 trials), "EGFR Mutation" (1 trials), "HER2 Mutation" (1 trials) and "Solid Tumors Harboring NTRK Fusion" (1 trials). Many other conditions were trialed in "Institut Curie - Ulm - Paris" in a lesser frequency.

Most popular intervention types in "Institut Curie - Ulm - Paris" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BAY2927088_formulation A" (1 trials), "BAY2927088_formulation B_1" (1 trials), "BAY2927088_formulation B_2" (1 trials) and "Larotrectinib (Vitrakvi, BAY2757556)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Curie - Ulm - Paris" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut Curie - Ulm - Paris". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institut Curie - Ulm - Paris, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Curie - Ulm - Paris, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".